Microbiological and immunological strategies for treatment of inflammatory bowel disease

被引:23
作者
Steidler, L
机构
[1] Flanders Interuniv Inst Biotechnol, Dept Mol Biol, B-9000 Ghent, Belgium
[2] State Univ Ghent, B-9000 Ghent, Belgium
关键词
inflammatory bowel disease; immunological therapeutics; delivery; probiotics;
D O I
10.1016/S1286-4579(01)01476-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic inflammatory bowel diseases such as Crohn's disease or ulcerative colitis, affect around 1 in every 1 000 individuals in western countries. They probably result from an inappropriate reaction towards the commensal microflora and are currently treated with antiinflammatory drugs or surgery. Novel strategies aim at blocking lymphocyte recruitment and activation, improved targeting of therapeutics and modification of gut microflora. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:1157 / 1166
页数:10
相关论文
共 98 条
[1]   A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29 [J].
Adlerberth, I ;
Ahrne, S ;
Johansson, ML ;
Molin, G ;
Hanson, LA ;
Wold, AE .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1996, 62 (07) :2244-2251
[2]   Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo [J].
Atreya, R ;
Mudter, J ;
Finotto, S ;
Müllberg, J ;
Jostock, T ;
Wirtz, S ;
Schütz, M ;
Bartsch, B ;
Holtmann, M ;
Becker, C ;
Strand, D ;
Czaja, J ;
Schlaak, JF ;
Lehr, HA ;
Autschbach, F ;
Schürmann, G ;
Nishimoto, N ;
Yoshizaki, K ;
Ito, H ;
Kishimoto, T ;
Galle, PR ;
Rose-John, S ;
Neurath, MF .
NATURE MEDICINE, 2000, 6 (05) :583-588
[3]   Interleukin 10 gene transfer prevents experimental colitis in rats [J].
Barbara, G ;
Xing, Z ;
Hogaboam, CM ;
Gauldie, J ;
Collins, SM .
GUT, 2000, 46 (03) :344-349
[4]   Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses [J].
Berg, DJ ;
Davidson, N ;
Kuhn, R ;
Muller, W ;
Menon, S ;
Holland, G ;
ThompsonSnipes, L ;
Leach, MW ;
Rennick, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1010-1020
[5]  
Björkstén B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x
[6]  
BLAND PW, 1986, IMMUNOLOGY, V58, P9
[7]   Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4 [J].
Boirivant, M ;
Fuss, IJ ;
Chu, A ;
Strober, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) :1929-1939
[8]   Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis [J].
Boirivant, M ;
Marini, M ;
Di Felice, G ;
Pronio, AM ;
Montesani, C ;
Tersigni, R ;
Strober, W .
GASTROENTEROLOGY, 1999, 116 (03) :557-565
[9]   RAT INTESTINAL EPITHELIAL-CELLS PRESENT MAJOR HISTOCOMPATIBILITY COMPLEX ALLOPEPTIDES TO PRIMED T-CELLS [J].
BRANDEIS, JM ;
SAYEGH, MH ;
GALLON, L ;
BLUMBERG, RS ;
CARPENTER, CB .
GASTROENTEROLOGY, 1994, 107 (05) :1537-1542
[10]   Immune response to orally consumed antigens and probiotic bacteria [J].
Chin, J ;
Turner, B ;
Barchia, I ;
Mullbacher, A .
IMMUNOLOGY AND CELL BIOLOGY, 2000, 78 (01) :55-66